Teva Pharmaceutical Industries Ltd: Unternehmensprofil, Finanzberichte & Marktperformance

mehr Informationen über Teva Pharmaceutical Industries Ltd Unternehmen

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Teva Pharmaceutical Industries Ltd Informationen



BörsenkürzelTEVA

Name des UnternehmensTeva Pharmaceutical Industries Ltd

IPO-datumFeb 06, 2087

CEOFrancis (Richard D)

Anzahl der mitarbeiter33892

WertpapierartDepository Receipt

GeschäftsjahresendeFeb 06

Addresse124 Dvora Hanevi'a St.

StadtTEL AVIV-YAFO

BörseNASDAQ OMX NASDAQ Basic NYSE

LandIsrael

Postleitzahl6944020

Telefon97239148213

Websitehttps://www.tevapharm.com/

BörsenkürzelTEVA

IPO-datumFeb 06, 2087

CEOFrancis (Richard D)

Führungskräfte von Teva Pharmaceutical Industries Ltd



Name

Name/Position

Position

Aktienbesitz

Veränderung

Prof. Varda Shalev

Independent Director

22.50K

+9632.00%

Ms. Christine (Chris) Fox

Executive Vice President - U.S. Commercial

14.28K

+14280.00%

Mr. Amir Elstein

Independent Director

--

Mr. Mark Sabag

Executive Vice President - International Markets Commercial

--

Dr. Sol J. Barer, Ph.D.

Independent Chairman of the Board

--

Ms. Rosemary A. (Rose) Crane

Independent Director

--

Mr. Gerald M. (Jerry) Lieberman

Independent Director

--

Mr. Richard Daniell

Executive Vice President - European Commercial

--

Mr. Roberto A. Mignone

Independent Director

--

Dr. Perry D. Nisen, M.D., Ph.D.

Independent Director

--

Name

Name/Position

Position

Aktienbesitz

Veränderung

Prof. Varda Shalev

Independent Director

22.50K

+9632.00%

Ms. Christine (Chris) Fox

Executive Vice President - U.S. Commercial

14.28K

+14280.00%

Mr. Amir Elstein

Independent Director

--

Mr. Mark Sabag

Executive Vice President - International Markets Commercial

--

Dr. Sol J. Barer, Ph.D.

Independent Chairman of the Board

--

Ms. Rosemary A. (Rose) Crane

Independent Director

--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Generic products

2.58B

57.54%

AUSTEDO

609.00M

13.59%

Anda

392.00M

8.75%

Other

274.00M

6.12%

AJOVY

169.00M

3.77%

Andere

458.00M

10.22%

Nach RegionUSD

Name

Umsatz

Anteil

United States

2.48B

55.40%

Europe

1.24B

27.57%

International Markets

558.00M

12.46%

Other

205.00M

4.58%

Nach Geschäftsbereich

Nach Region

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Generic products

2.58B

57.54%

AUSTEDO

609.00M

13.59%

Anda

392.00M

8.75%

Other

274.00M

6.12%

AJOVY

169.00M

3.77%

Andere

458.00M

10.22%

Aktionärsstatistik

Aktualisiert: Sun, Jan 11

Aktionäre

Aktionärstypen

Aktionäre

Anteil

Harel Insurance Investments and Financial Services Ltd

3.91%

Phoenix Investment and Finances Ltd

3.57%

Menora Mivtachim Insurance Ltd.

3.38%

Migdal Insurance and Financial Holdings Ltd

3.25%

BlackRock Institutional Trust Company, N.A.

3.04%

Andere

82.84%

Aktionäre

Anteil

Harel Insurance Investments and Financial Services Ltd

3.91%

Phoenix Investment and Finances Ltd

3.57%

Menora Mivtachim Insurance Ltd.

3.38%

Migdal Insurance and Financial Holdings Ltd

3.25%

BlackRock Institutional Trust Company, N.A.

3.04%

Andere

82.84%

Aktionärstypen

Aktionäre

Anteil

Investment Advisor

23.09%

Investment Advisor/Hedge Fund

12.52%

Hedge Fund

10.42%

Insurance Company

6.65%

Research Firm

2.35%

Family Office

1.86%

Pension Fund

1.56%

Bank and Trust

0.85%

Sovereign Wealth Fund

0.24%

Andere

40.48%

Institutionelle Beteiligung



Aktualisiert: Thu, Jan 1

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2025Q4

1165

666.08M

57.93%

-136.04M

2025Q3

1124

742.23M

64.70%

-84.92M

2025Q2

1100

749.18M

65.31%

-13.97M

2025Q1

1130

727.69M

63.46%

-282.41K

2024Q4

1087

683.52M

59.66%

-22.86M

2024Q3

1029

663.95M

58.60%

-6.13M

2024Q2

1002

631.05M

55.72%

-26.20M

2024Q1

950

595.83M

53.15%

-34.73M

2023Q4

932

601.27M

53.63%

+7.51M

2023Q3

929

573.53M

51.16%

-84.22M

Aktionärsaktivitäten



Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

Harel Insurance Investments and Financial Services Ltd

37.70M

3.29%

+4.31M

+12.90%

Sep 30, 2025

Phoenix Investment and Finances Ltd

41.30M

3.6%

+3.53M

+9.36%

Sep 30, 2025

Menora Mivtachim Insurance Ltd.

38.92M

3.39%

-18.47M

-32.19%

Sep 30, 2025

Migdal Insurance and Financial Holdings Ltd

32.58M

2.84%

+3.90M

+13.58%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

34.92M

3.04%

+1.03M

+3.04%

Sep 30, 2025

Clal Insurance Enterprises Holdings Ltd.

31.49M

2.74%

-876.00K

-2.71%

Sep 30, 2025

Lingotto Investment Management LLP

28.59M

2.49%

+431.87K

+1.53%

Sep 30, 2025

Rubric Capital Management LP

24.65M

2.15%

-1.35M

-5.19%

Sep 30, 2025

PointState Capital LP

20.71M

1.81%

--

Sep 30, 2025

Fidelity Management & Research Company LLC

20.19M

1.76%

-30.45M

-60.13%

Sep 30, 2025

Verbundene ETFs



Aktualisiert: Sat, Dec 6

Name

Anteil

iShares MSCI Israel ETF

7.76%

VanEck Israel ETF

7.5%

VanEck Pharmaceutical ETF

3.79%

First Trust WCM Developing World Equity ETF

3.16%

First Trust WCM International Equity ETF

2.64%

ARK Israel Innovative Technology ETF

1.81%

WealthTrust DBS Long Term Growth ETF

1.42%

WisdomTree International Multifactor Fund

0.77%

iShares Health Innovation Active ETF

0.69%

iShares MSCI Intl Value Factor ETF

0.46%

iShares MSCI Israel ETF

Anteil7.76%

VanEck Israel ETF

Anteil7.5%

VanEck Pharmaceutical ETF

Anteil3.79%

First Trust WCM Developing World Equity ETF

Anteil3.16%

First Trust WCM International Equity ETF

Anteil2.64%

ARK Israel Innovative Technology ETF

Anteil1.81%

WealthTrust DBS Long Term Growth ETF

Anteil1.42%

WisdomTree International Multifactor Fund

Anteil0.77%

iShares Health Innovation Active ETF

Anteil0.69%

iShares MSCI Intl Value Factor ETF

Anteil0.46%

Dividende



In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Keine Daten

Aktien-Split



Datum

Ex-Dividendentag

Art

Verhältnis

Keine Daten

Datum

Ex-Dividendentag

Art

Verhältnis

Keine Daten